Monte Rosa Therapeutics Statistics
NASDAQ: GLUEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
9.86-0.31 (-3.05%)
Market open · Delayed 15 min · as of Oct 8, 12:44 PM ET
Monte Rosa Therapeutics by the numbers
Monte Rosa Therapeutics has a market capitalization of $841.2 million based on 85.31M shares outstanding. With trailing EPS of $-1.75, Monte Rosa Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.9% below its 50-day average and 45.5% below its 200-day average.
Average daily trading volume is 1.31M shares, or about $13.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GLUE valuation vs. peer median
| Metric | GLUE | Peer median | Difference |
|---|---|---|---|
| Market cap | $841.19M | $833.50M | +1% |
| Avg. volume | 1.31M | 834.22K | +58% |
Peer median across 8 companies: ODTX, SLBT, SANA, CGEM, DNA, MGTX, ATTO, CADL.
Valuation
- Market cap
- $841.19M
- EPS (TTM)
- $-1.75
- Shares outstanding
- 85.31M
Price and trading
- Previous close
- 10.17
- Open
- 10.04
- Day range
- 9.82 – 10.05
- 52-week range
- 7.65 – 25.77
- 52-week change
- +37.80%
- Beta
- —
- Volume
- 272.99K
- Average volume
- 1.31M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 841.19M
- Forward Pe
- -5.06
- Eps
- -1.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 25.77
- Week52 Low
- 7.65
- Avg Volume
- 1.31M
- Shares Outstanding
- 85.31M
- Ma50
- 14.07
- Ma200
- 18.09
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -61.74%
- Pct From52w Low
- 28.97%